HISTOCOMPATIBILITY ANTIGENS ON MOUSE BLASTOCYSTS AND ECTOPLACENTAL CONES
Michel Vandeputte, H. Sobis
openalex +1 more source
Comparison of amino acid sequences of two human histocompatibility antigens, HLA-A2 and HLA-B7: location of putative alloantigenic sites. [PDF]
Harry T. Orr+4 more
openalex +1 more source
The convergent synthesis of Lewis‐X‐containing betulinic acid and echinocystic acid saponins (1 and 2) is presented. The synthetic saponins were shown to inhibit, at the low micromolar range, the DC‐SIGN‐ and L‐SIGN‐mediated transfer of HIV‐1 infection to CD4‐positive cells, whereas free Lewis‐X, aglycones, and structurally similar triterpenoid ...
Oscar Javier Gamboa Marin+5 more
wiley +1 more source
DapPep: Domain Adaptive Peptide-agnostic Learning for Universal T-cell Receptor-antigen Binding Affinity Prediction [PDF]
Identifying T-cell receptors (TCRs) that interact with antigenic peptides provides the technical basis for developing vaccines and immunotherapies. The emergent deep learning methods excel at learning antigen binding patterns from known TCRs but struggle with novel or sparsely represented antigens.
arxiv
HISTOCOMPATIBILITY ANTIGENS ON THE SURFACE OF CULTIVATED EPIDERMAL CELLS FROM MOUSE EMBRYO SKIN
P. Worst, Norbert E. Fusenig
openalex +1 more source
Effect of Vesicular Stomatitis Virus Infection on the Histocompatibility Antigen of L Cells [PDF]
Toby T. Hecht, Donald F. Summers
openalex +1 more source
CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II. [PDF]
van Balen P+10 more
europepmc +1 more source
HL-A histocompatibility antigens and cutaneous reactions to practolol
S Wadskov+4 more
openalex +2 more sources
Stimulation of Mouse Migration Inhibitory Factor (MIF) Production from MSV-Immune Lymphocytes by Soluble Tumor-Associated Antigen: Requirement for Histocompatible Macrophages [PDF]
Santo Landolfo+2 more
openalex +1 more source
Optimizing target engagement for bispecific antibodies (bsAbs) is challenging, as bsAbs bind to two different targets in vivo to form a trimolecular complex (trimer), and likely display a bell‐shaped concentration–response curve. bsAbs trimer formation is expected to be related to efficacy and safety, and determining the dose level at which it is ...
Gaurav Bajaj+16 more
wiley +1 more source